{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T03:37:21Z","timestamp":1773113841582,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","pathologyjournal.rcpa.edu.au","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.pathol.2020.10.019","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T04:01:48Z","timestamp":1613880108000},"page":"595-601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Primary cutaneous methotrexate-associated B-cell lymphoproliferative disorders other than EBV-positive mucocutaneous ulcer: clinical, pathological, and immunophenotypic features"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7921-6087","authenticated-orcid":false,"given":"Akira","family":"Satou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Banno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9219-8357","authenticated-orcid":false,"given":"Taishi","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8284-567X","authenticated-orcid":false,"given":"Emiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Nobata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7187-0463","authenticated-orcid":false,"given":"Shiho","family":"Iwagaitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6817-3993","authenticated-orcid":false,"given":"Daisuke","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6681-8927","authenticated-orcid":false,"given":"Ichiro","family":"Hanamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1822-9976","authenticated-orcid":false,"given":"Akiyoshi","family":"Takami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4855-4366","authenticated-orcid":false,"given":"Toyonori","family":"Tsuzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2020.10.019_bib1","first-page":"S52","article-title":"Drug combinations with methotrexate to treat rheumatoid arthritis","volume":"28","author":"Rath","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.pathol.2020.10.019_bib2","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","year":"2017"},{"key":"10.1016\/j.pathol.2020.10.019_bib3","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/s41379-019-0264-2","article-title":"Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 cases","volume":"32","author":"Satou","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2020.10.019_bib4","first-page":"322","article-title":"Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication","volume":"34","author":"Hoshida","year":"2007","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.pathol.2020.10.019_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ejh.12116","article-title":"Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression","volume":"91","author":"Ichikawa","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.pathol.2020.10.019_bib6","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/PAS.0000000000001271","article-title":"Methotrexate-associated lymphoproliferative disorders in patients with rheumatoid arthritis: clinicopathologic features and prognostic factors","volume":"43","author":"Kurita","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2020.10.019_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3899\/jrheum.130270","article-title":"A\u00a0clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders","volume":"41","author":"Yamakawa","year":"2014","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.pathol.2020.10.019_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","article-title":"EBV positive mucocutaneous ulcer\u2013a study of 26 cases associated with various sources of immunosuppression","volume":"34","author":"Dojcinov","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2020.10.019_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/PAS.0000000000001186","article-title":"The spectrum of EBV-positive mucocutaneous ulcer: a study of 9 cases","volume":"43","author":"Prieto-Torres","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2020.10.019_bib10","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/his.13464","article-title":"Comparison of Epstein-Barr virus-positive mucocutaneous ulcer associated with treated lymphoma or methotrexate in Japan","volume":"72","author":"Daroontum","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2020.10.019_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/pin.12745","article-title":"EBV-positive mucocutaneous ulcer arising in rheumatoid arthritis patients treated with methotrexate: single center series of nine cases","volume":"69","author":"Satou","year":"2019","journal-title":"Pathol Int"},{"key":"10.1016\/j.pathol.2020.10.019_bib12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1600-0560.1999.tb01837.x","article-title":"Epstein Barr virus-associated lymphoproliferative-disorders primarily involving the skin","volume":"26","author":"Chai","year":"1999","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.pathol.2020.10.019_bib13","first-page":"1546","article-title":"Primary cutaneous B cell lymphoma during methotrexate therapy for rheumatoid arthritis","volume":"27","author":"Fam","year":"2000","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.pathol.2020.10.019_bib14","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0025-6196(11)63231-X","article-title":"Cutaneous lymphoma associated with Epstein-Barr virus infection in 2 patients treated with methotrexate","volume":"76","author":"Tournadre","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.pathol.2020.10.019_bib15","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.jaad.2005.09.015","article-title":"Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after withdrawal of methotrexate therapy for rheumatoid arthritis","volume":"57","author":"Maruani","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pathol.2020.10.019_bib16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaad.2008.10.051","article-title":"Methotrexate-related lymphoproliferative disorder with extensive vascular involvement in a patient with rheumatoid arthritis","volume":"61","author":"Shimura","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pathol.2020.10.019_bib17","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/PAS.0000000000000225","article-title":"Methotrexate-associated B-cell lymphoproliferative disorders presenting in the skin: a clinicopathologic and immunophenotypical study of 10 cases","volume":"38","author":"Koens","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2020.10.019_bib18","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2340\/00015555-1951","article-title":"Cutaneous manifestations of methotrexate-associated lymphoproliferative disorders: report of two cases and a review of the literature","volume":"95","author":"Shimizu","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.pathol.2020.10.019_bib19","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jaad.2006.09.011","article-title":"Methotrexate-associated lymphoproliferative disorder in a patient with rheumatoid arthritis presenting in the skin","volume":"56","author":"Clarke","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pathol.2020.10.019_bib20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2230.2009.03293.x","article-title":"Methotrexate-induced primary cutaneous diffuse large B-cell lymphoma with an 'angiocentric' histological morphology","volume":"35","author":"Pfistershammer","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.pathol.2020.10.019_bib21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2133.1996.tb03621.x","article-title":"Reversible cutaneous lymphoma occurring during methotrexate therapy","volume":"135","author":"Viraben","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.pathol.2020.10.019_bib22","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.pas.0000173238.17331.6b","article-title":"Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified","volume":"29","author":"Asano","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2020.10.019_bib23","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2020.10.019_bib24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2020.10.019_bib25","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood.V99.3.815","article-title":"De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients","volume":"99","author":"Yamaguchi","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2020.10.019_bib26","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3324\/haematol.12810","article-title":"De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients","volume":"93","author":"Yamaguchi","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2020.10.019_bib27","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1349-7006.2010.01517.x","article-title":"Clinicopathologic correlations of diffuse large B-cell lymphoma in rheumatoid arthritis patients treated with methotrexate","volume":"101","author":"Niitsu","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.pathol.2020.10.019_bib28","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000058320","article-title":"De novo CD5-positive diffuse large B cell lymphoma solely presenting as multiple subcutaneous nodules","volume":"107","author":"Takahashi","year":"2002","journal-title":"Acta Haematol"},{"key":"10.1016\/j.pathol.2020.10.019_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0065-2776(08)60663-X","article-title":"The CD5 B cell","volume":"47","author":"Kipps","year":"1989","journal-title":"Adv Immunol"},{"key":"10.1016\/j.pathol.2020.10.019_bib30","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1172\/JCI119691","article-title":"Molecular single-cell analysis reveals that CD5-positive peripheral blood B cells in healthy humans are characterized by rearranged Vkappa genes lacking somatic mutation","volume":"100","author":"Fischer","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pathol.2020.10.019_bib31","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrclinonc.2009.169","article-title":"Gamma-delta T-cell lymphomas","volume":"6","author":"Tripodo","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.pathol.2020.10.019_bib32","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/ni.2773","article-title":"Innate-like T cells straddle innate and adaptive immunity by altering antigen-receptor responsiveness","volume":"15","author":"Wencker","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.pathol.2020.10.019_bib33","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nri2781","article-title":"Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity","volume":"10","author":"Bonneville","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.pathol.2020.10.019_bib34","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41577-018-0061-z","article-title":"Natural killer cells and other innate lymphoid cells in cancer","volume":"18","author":"Chiossone","year":"2018","journal-title":"Nat Rev Immunol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302521000295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302521000295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T10:16:59Z","timestamp":1626344219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302521000295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0031302521000295"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2020.10.019","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary cutaneous methotrexate-associated B-cell lymphoproliferative disorders other than EBV-positive mucocutaneous ulcer: clinical, pathological, and immunophenotypic features","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2020.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}